Medici Brands, Inc.

Based in the US, Medici Brands, Inc. , operates as a consumer packaged goods platform that develops, acquires, and manages food and nutrition brands. Based in New York, the US and founded in 2025, Medici Brands, Inc. is a consumer packaged goods platform.

In August 2026, Medici Brands, Inc. raised USD 270. 92 mn in Series B funding by Greenoaks Capital, ICONIQ Capital, Imaginary Ventures, and Valor Equity Partners. The company intends to use the funding to expand HallPass and David Protein, advance product innovation, and support the launch and growth of new brands, including Rowdy.

Medici's core offerings revolve around creating and enhancing unique brands that primarily focus on indulgent food and lifestyle experiences. Their flagship products include HallPass, promoting enjoyable dining experiences, and Epogee, representing a new standard in indulgent food choices. Medici targets both individual customers and businesses within the food and tech industries, reflecting a commitment to innovation and customer engagement. Their products are marketed and sold in multiple geographical regions, including North America and select markets in Europe.

Medici generates its revenue through a combination of direct-to-consumer sales and partnerships with retailers and wholesalers, facilitating a broad distribution network for its product offerings. The transaction structure includes subscription models for exclusive access to new product launches and partnerships that enhance brand visibility across various platforms. Medici emphasizes cultivating strong connections with both its B2B partners and individual consumers, creating a sustainable revenue ecosystem grounded in brand loyalty and satisfaction. The company plans to expand HallPass and David Protein, advance product innovation, and support the launch and growth of new brands, including Rowdy.